• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

终末期肾病患者院内心肺脑复苏后的发病率和存活率:一项全国范围内基于人群的研究。

The incidence and survival after in-hospital cardiopulmonary cerebral resuscitation in end-stage kidney disease patients: A nationwide population-based study.

机构信息

Department of Cardiology, New Taipei Municipal TuCheng Hospital, Chang Gung Memorial Hospital and Chang Gung University.

Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.

出版信息

PLoS One. 2020 Aug 28;15(8):e0238029. doi: 10.1371/journal.pone.0238029. eCollection 2020.

DOI:10.1371/journal.pone.0238029
PMID:32857782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7454972/
Abstract

BACKGROUND

This study analyzed the survival and protective predictors of in-hospital cardiopulmonary cerebral resuscitation (CPCR) to potentially help physicians create effective treatment plans for End-stage kidney disease (ESKD) patients.

METHODS

We extracted the data of 7,116 ESKD patients who received their first in-hospital CPCR after initial dialysis between 2004 and 2012 from the National Health Insurance Research Database. The primary outcome was the survival rate during the first in-hospital CPCR. The secondary outcome was the median post-discharge survival.

RESULTS

From 2004 through 2012, the incidence of in-hospital CPCR decreases from 3.97 to 3.67 events per 1,000 admission days (P for linear trend <0.001). The survival rate for the first in-hospital CPCR did not change significantly across the 9 years (P for trend = 0.244), whereas the median survival of post-discharge survival increased significantly from 3.0 months in 2004 to 6.8 months in 2011 (P for linear trend <0.001). In addition, multivariable analysis identified older age as a risk factor and prior intracardiac defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) implantation as a protective factor for in-hospital death during the first in-hospital CPCR.

CONCLUSION

The incidence of in-hospital CPCR and the duration post-discharge among ESKD patients improved despite there being no significant difference in the survival rate of ESKD patients after CPCP. Either ICD or CRT-D implantation may be advisable for ESKD patients with a high risk of sudden cardiac death.

摘要

背景

本研究分析了院内心肺复苏(CPCR)的生存和保护预测因素,以期帮助医生为终末期肾病(ESKD)患者制定有效的治疗计划。

方法

我们从国家健康保险研究数据库中提取了 2004 年至 2012 年间首次接受初始透析后院内首次 CPCR 的 7116 名 ESKD 患者的数据。主要结局是首次院内 CPCR 期间的生存率。次要结局是出院后中位生存时间。

结果

2004 年至 2012 年,院内 CPCR 的发生率从每 1000 个入院日 3.97 例降至 3.67 例(P 趋势<0.001)。9 年间首次院内 CPCR 的生存率无显著变化(趋势 P=0.244),而出院后中位生存时间从 2004 年的 3.0 个月显著增加到 2011 年的 6.8 个月(线性趋势 P<0.001)。此外,多变量分析确定年龄较大是院内死亡的危险因素,而先前植入心脏内除颤器(ICD)或心脏再同步治疗除颤器(CRT-D)是院内 CPCR 期间院内死亡的保护因素。

结论

尽管 ESKD 患者 CPCR 后生存率无显著差异,但 ESKD 患者院内 CPCR 的发生率和出院后持续时间有所改善。对于有突发心脏死亡高风险的 ESKD 患者,植入 ICD 或 CRT-D 可能是明智的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0f/7454972/be4443d89b48/pone.0238029.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0f/7454972/093c1f092185/pone.0238029.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0f/7454972/ee1f2a2e4e79/pone.0238029.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0f/7454972/be4443d89b48/pone.0238029.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0f/7454972/093c1f092185/pone.0238029.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0f/7454972/ee1f2a2e4e79/pone.0238029.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d0f/7454972/be4443d89b48/pone.0238029.g003.jpg

相似文献

1
The incidence and survival after in-hospital cardiopulmonary cerebral resuscitation in end-stage kidney disease patients: A nationwide population-based study.终末期肾病患者院内心肺脑复苏后的发病率和存活率:一项全国范围内基于人群的研究。
PLoS One. 2020 Aug 28;15(8):e0238029. doi: 10.1371/journal.pone.0238029. eCollection 2020.
2
Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.植入式心脏复律除颤器与2001年至2012年丹麦急性心肌梗死所致院外心脏骤停后的生存率:一项全国性研究
Eur Heart J Acute Cardiovasc Care. 2017 Mar;6(2):144-154. doi: 10.1177/2048872616687115. Epub 2017 Jan 6.
3
Primary prevention implantable cardioverter defibrillators in end-stage kidney disease patients on dialysis: a matched cohort study.终末期肾病透析患者的一级预防植入式心脏复律除颤器:一项匹配队列研究。
Nephrol Dial Transplant. 2015 May;30(5):829-35. doi: 10.1093/ndt/gfu274. Epub 2014 Nov 17.
4
Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.透析患者中植入式心脏转复除颤器的预防性应用预防心源性猝死。
Circulation. 2019 Jun 4;139(23):2628-2638. doi: 10.1161/CIRCULATIONAHA.119.039818. Epub 2019 Mar 18.
5
Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis.接受透析治疗的终末期肾病患者皮下植入式心脏复律除颤器植入的结果
J Cardiovasc Electrophysiol. 2015 Aug;26(8):900-904. doi: 10.1111/jce.12705. Epub 2015 Jun 16.
6
Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.无再同步功能的心脏除颤器植入后患者生存率的决定因素。
Kardiol Pol. 2012;70(11):1099-110.
7
Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients.肾透析作为植入式心脏复律除颤器接受者适当治疗和死亡率的一个危险因素。
Heart Rhythm. 2006 Oct;3(10):1196-201. doi: 10.1016/j.hrthm.2006.06.013. Epub 2006 Jul 8.
8
Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.非缺血性患者中植入预防性 ICD 和 CRT-D 的长期预后:来自全国范围内远程监测传输日常数据库的分析。
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1626-1635. doi: 10.1111/jce.14006. Epub 2019 Jun 18.
9
Trends in in-hospital cardiopulmonary resuscitation and survival in adults receiving maintenance dialysis.接受维持性透析的成人患者院内心肺复苏及生存趋势
JAMA Intern Med. 2015 Jun;175(6):1028-35. doi: 10.1001/jamainternmed.2015.0406.
10
Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.尽管采用植入式心脏除颤器(ICD)治疗以一级预防心源性猝死,但慢性肾脏病患者的预后仍较差。
Pacing Clin Electrophysiol. 2007 Feb;30(2):207-13. doi: 10.1111/j.1540-8159.2007.00651.x.

引用本文的文献

1
Longitudinal analysis of in-hospital cardiac arrest: trends in the incidence, mortality, and long-term survival of a nationwide cohort.住院心脏骤停的纵向分析:全国队列的发病率、死亡率及长期生存率趋势
Crit Care. 2025 Jan 23;29(1):41. doi: 10.1186/s13054-025-05274-1.

本文引用的文献

1
Cardiopulmonary Resuscitation in Outpatient Dialysis Clinics: Perception of Futility?门诊透析诊所中的心肺复苏:对无意义的认知?
J Am Soc Nephrol. 2019 Mar;30(3):369-370. doi: 10.1681/ASN.2019010046. Epub 2019 Feb 7.
2
Does a Supplemental Low-Protein Diet Decrease Mortality and Adverse Events After Commencing Dialysis? A Nationwide Cohort Study.补充低蛋白饮食是否能降低开始透析后的死亡率和不良事件?一项全国性队列研究。
Nutrients. 2018 Aug 8;10(8):1035. doi: 10.3390/nu10081035.
3
Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same?
免疫抑制疗法对肾移植中动脉僵硬度的影响:所有治疗方法都一样吗?
Clin Kidney J. 2018 Jun;11(3):413-421. doi: 10.1093/ckj/sfx120. Epub 2017 Nov 23.
4
Impact of dialysis dependence on prognosis in patients with myocardial infarction: An 11-year population-based study.透析依赖对心肌梗死患者预后的影响:一项基于人群的11年研究。
Medicine (Baltimore). 2018 Feb;97(6):e9833. doi: 10.1097/MD.0000000000009833.
5
Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.急性心肌梗死后透析患者中使用中等至高强度他汀类药物:亚洲的一项全国队列研究。
Atherosclerosis. 2017 Dec;267:158-166. doi: 10.1016/j.atherosclerosis.2017.09.018. Epub 2017 Sep 27.
6
Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.植入式心脏复律除颤器与射血分数改善和未改善的心力衰竭患者生存的相关性:心力衰竭猝死试验的二次分析。
JAMA Cardiol. 2017 Jul 1;2(7):767-774. doi: 10.1001/jamacardio.2017.1413.
7
Early predictors of poor outcome after out-of-hospital cardiac arrest.院外心脏骤停后预后不良的早期预测指标。
Crit Care. 2017 Apr 13;21(1):96. doi: 10.1186/s13054-017-1677-2.
8
Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.卡维地洛、比索洛尔和美托洛尔控释/缓释制剂对心力衰竭血液透析患者的预后益处:一项为期10年的队列研究
J Am Heart Assoc. 2016 Jan 6;5(1):e002584. doi: 10.1161/JAHA.115.002584.
9
Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database.全国人口科学:来自台湾全民健康保险研究数据库的经验教训。
JAMA Intern Med. 2015 Sep;175(9):1527-9. doi: 10.1001/jamainternmed.2015.3540.
10
United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.美国肾脏数据系统对慢性肾脏病和终末期肾病的公共卫生监测。
Kidney Int Suppl (2011). 2015 Jun;5(1):2-7. doi: 10.1038/kisup.2015.2.